Yunnan Baiyao Group Co.,Ltd
000538
Rank in Stocks
#1530
Operating globally and domestically within China, Yunnan Baiyao Group Co., Ltd.... Operating globally and domestically within China, Yunnan Baiyao Group Co., Ltd. specializes in the pharmaceutical industry. Its diverse portfolio encompasses health supplements, a wide array of medications, medical devices, traditional Chinese medicine ingredients, and even tea. These offerings are marketed under various brand identities, including Yunnan Baiyao, Yunfeng, Tong Qiaoqiao, Yunjian, Life, Jinkoujian, Langjian, Yangyuanqing, Caizhiji, Baiyao Health, Leopard Seven, Qiancaotang, Qiancao Meizi, and Tianzihong. The company, established in 1902, maintains its principal offices in Kunming, China.
Share Price
$7.90
Last synced: 2026-10-22
Market Cap
$14.09B
Change (1 day)
-0.13%
Change (1 year)
-0.53%
Country
CN
Trade Yunnan Baiyao Group Co.,Ltd (000538)
Category
Healthcare
Revenue for Yunnan Baiyao Group Co.,Ltd (000538)
Revenue in Jun 2026 TTM: $6.25B
According to Yunnan Baiyao Group Co.,Ltd latest financial reports the company's current revenue (TTM) is $6.25B. In 2024 the company made a revenue of $5.48B a decrease compared to the revenue in the year 2023 that was $5.53B. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Yunnan Baiyao Group Co.,Ltd from 2001 to 2026
Revenue at the end of each year
| Year | Revenue | Change |
|---|---|---|
| 2026 (TTM) | $6.25B | 6.25% |
| 2025 | $5.89B | 7.33% |
| 2024 | $5.48B | -0.73% |
| 2023 | $5.53B | 4.45% |
| 2022 | $5.29B | -7.57% |
| 2021 | $5.72B | 14.18% |
| 2020 | $5.01B | 17.65% |
| 2019 | $4.26B | 8.46% |
| 2018 | $3.93B | 5.10% |
| 2017 | $3.74B | 15.78% |
| 2016 | $3.23B | 1.07% |
| 2015 | $3.19B | 5.14% |
| 2014 | $3.04B | 16.50% |
| 2013 | $2.61B | 17.68% |
| 2012 | $2.22B | 23.46% |
| 2011 | $1.79B | 17.55% |
| 2010 | $1.53B | 45.31% |
| 2009 | $1.05B | 25.24% |
| 2008 | $838.74M | 48.80% |
| 2007 | $563.67M | 37.49% |
| 2006 | $409.97M | 35.16% |
| 2005 | $303.33M | 37.00% |
| 2004 | $221.41M | 36.25% |
| 2003 | $162.50M | 22.17% |
| 2002 | $133.01M | 22.26% |
| 2001 | $108.80M | 0.00% |
Revenue for similar companies or competitors
| Company | Revenue | Revenue Difference | Country |
|---|---|---|---|
| $23.54B | 276.26% |
DE
|
|
| $23.73B | 279.46% |
DE
|
|
| $29.24B | 367.46% |
JP
|
|
| $5.85B | -6.49% |
CH
|
|
| $6.34B | 1.40% |
IN
|
